On June, 6 Mesa Laboratories, Inc. (MLAB) EPS Estimated At $1.93

May 17, 2018 - By Elizabeth Jones

Mesa Laboratories, Inc. (NASDAQ:MLAB) Corporate Logo
During Q4 2017 the big money sentiment decreased to 1.21. That’s change of 0.67, from 2017Q3’s 1.88. 12 investors sold all, 26 reduced holdings as Mesa Laboratories, Inc. ratio dropped. 37 rose stakes while 9 funds amassed stakes. Funds hold 2.66 million shares thus 6.81% more from 2017Q3’s 2.49 million shares.
5,702 are owned by Swiss Bancorp. Comerica National Bank & Trust reported 6,481 shs. California Employees Retirement System stated it has 9,800 shs or 0% of all its holdings. 7,990 are owned by Tiaa Cref Invest Management Ltd. Navellier Associates has 0.04% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 1,832 shs. Royal Bancorp Of Canada reported 0% of its capital in Mesa Laboratories, Inc. (NASDAQ:MLAB). New York-based Renaissance Technology Ltd Liability Company has invested 0.01% in Mesa Laboratories, Inc. (NASDAQ:MLAB). State Street, Massachusetts-based fund reported 59,085 shs. Thomson Horstmann And Bryant owns 1.45% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 88,379 shs. Raymond James Financial Svcs Advisors Inc invested in 11,678 shs. 17,234 are owned by Commercial Bank Of Ny Mellon. Price T Rowe Md holds 0% or 179,314 shs in its capital. Dimensional Fund Advisors Lp owns 0.01% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 134,152 shs. Ameritas Inv Inc invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Credit Suisse Ag invested in 3,012 shs.

Mesa Laboratories, Inc. registered $1.27 million net activity with 0 insider purchases and 2 sales since February 15, 2018. Dwyer Robert V sold $720,055 worth of stock.

Mesa Laboratories, Inc. (NASDAQ:MLAB) is awaited to announce earnings on June, 6., according to RTT. Analysts predict $1.93 EPS. That’s $0.69 up or 55.65 % from 2017’s earnings of $1.24. If reported the P/E will be 21.99 with $7.30 million profit. Analysts at Wall Street see Mesa Laboratories, Inc.’s -904.17 % EPS growth compared to $-0.24 EPS for last quarter. MLAB is touching $169.8 during the last trading session, after decreased 0.97%.Currently Mesa Laboratories, Inc. is uptrending after 13.08% change in last May 17, 2017. MLAB has also 9,754 shares volume. The stock outperformed the S&P500 by 1.53%.

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products.The firm is worth $642.38 million. The company??s Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.Last it reported negative earnings. This segment??s products are used in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling, and semiconductor industries.

Mesa Laboratories, Inc. (NASDAQ:MLAB) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: